Chakravarthy B R, Isaacs R J, Morley P, Whitfield J F
Institute for Biological Sciences, National Research Council of Canada, Ottawa, Ontario, Canada.
J Biol Chem. 1995 Oct 20;270(42):24911-6. doi: 10.1074/jbc.270.42.24911.
Ionomycin stimulated membrane-associated protein kinase Cs (PKCs) activity in C6 rat glioma cells as much as the potent PKCs stimulator 12-O-tetradecanoyl phorbol 13-acetate (TPA). However, while TPA, as expected, powerfully stimulated the phosphorylation of the PKCs' 85-kDa myristoylated alanine-rich protein kinase C substrate (MARCKS) protein, ionomycin unexpectedly did not. Instead, ionomycin reduced the basal MARCKS phosphorylation. Pretreating the glioma cells with ionomycin prevented TPA-stimulated PKCs from phosphorylating the MARCKS protein. The stimulation of membrane PKCs activity and the prevention of MARCKS phosphorylation by ionomycin required external Ca2+ because they were both abolished by adding 5 mM EGTA to the culture medium. Recently (Chakravarthy, B. R., Isaacs, R. J., Morley, P., Durkin, J. P., and Whitfield, J. F. (1995) J. Biol. Chem. 270, 1362-1368), we proposed that Ca2+ x calmodulin complexes block MARCKS phosphorylation by the activated PKCs in keratinocytes stimulated by raising the external Ca2+ concentration. In the present experiments calmodulin prevented MARCKS phosphorylation by TPA-stimulated PKCs in glioma cell lysates, and this blockade was lifted by a calmodulin antagonist, the calmodulin-binding domain peptide. But, physiologically more significant, pretreating intact glioma cells with a cell-permeable calmodulin antagonist, calmidazolium, prevented ionomycin from blocking MARCKS phosphorylation by PKCs in unstimulated and TPA-stimulated cells. The effect of ionomycin on MARCKS phosphorylation was not due to the stimulation of Ca2+ x calmodulin-dependent phosphoprotein phosphatase, calcineurin, because cyclosporin A, a potent inhibitor of this phosphatase, did not stop ionomycin from preventing MARCKS phosphorylation. The ability of ionomycin to prevent TPA-stimulated PKCs from phosphorylating MARCKS depended on whether ionomycin was added before, with, or after TPA. Maximum blockade occurred when ionomycin was added before TPA but was less effective when added with or after TPA. These results indicate that Ca2+ x calmodulin can profoundly affect PKCs' signaling at the substrate level.
离子霉素刺激C6大鼠胶质瘤细胞中与膜相关的蛋白激酶C(PKCs)的活性,其程度与强效的PKCs刺激剂12 - O - 十四烷酰佛波醇13 - 乙酸酯(TPA)相同。然而,正如预期的那样,TPA有力地刺激了PKCs的85 kDa肉豆蔻酰化富含丙氨酸的蛋白激酶C底物(MARCKS)蛋白的磷酸化,而离子霉素却意外地没有。相反,离子霉素降低了MARCKS的基础磷酸化水平。用离子霉素预处理胶质瘤细胞可阻止TPA刺激的PKCs对MARCKS蛋白进行磷酸化。离子霉素对膜PKCs活性的刺激以及对MARCKS磷酸化的阻止需要细胞外Ca2+,因为向培养基中添加5 mM乙二醇双(氨基乙基醚)四乙酸(EGTA)会消除这两种作用。最近(查克拉瓦蒂,B.R.,艾萨克斯,R.J.,莫利,P.,德金,J.P.,和惠特菲尔德,J.F.(1995年)《生物化学杂志》270,1362 - 1368),我们提出Ca2+·钙调蛋白复合物在通过提高细胞外Ca2+浓度刺激的角质形成细胞中,可阻止活化的PKCs对MARCKS进行磷酸化。在本实验中,钙调蛋白在胶质瘤细胞裂解物中阻止了TPA刺激的PKCs对MARCKS的磷酸化,而这种阻断作用可被钙调蛋白拮抗剂——钙调蛋白结合域肽解除。但是,在生理上更具意义的是,用一种可穿透细胞的钙调蛋白拮抗剂氯米达唑预处理完整的胶质瘤细胞,可阻止离子霉素在未刺激和TPA刺激的细胞中阻断PKCs对MARCKS的磷酸化。离子霉素对MARCKS磷酸化的影响并非由于刺激了Ca2+·钙调蛋白依赖性磷蛋白磷酸酶——钙调神经磷酸酶,因为该磷酸酶的强效抑制剂环孢素A并不能阻止离子霉素对MARCKS磷酸化的阻止作用有关。离子霉素阻止TPA刺激的PKCs对MARCKS磷酸化的能力取决于离子霉素是在TPA之前、与TPA同时还是在TPA之后添加。当离子霉素在TPA之前添加时,阻断作用最大,而在与TPA同时或在TPA之后添加时效果较差。这些结果表明,Ca2+·钙调蛋白可在底物水平上深刻影响PKCs的信号传导。